Posted on January 28, 2021
This past year has seen the rapid development and testing of many COVID-19 vaccine candidates. But are vaccines solid investments? Is it worth purchasing the stocks of companies whose vaccines are in development? On the face of it, one can’t ignore the rollout of a product that will be demanded by eight billion people. But there’s always more to the story. We caution investors against thinking that the rollout of a safe and effective vaccine for COVID-19 automatically leads to an outperforming stock. Several factors need to be considered.
Posted on January 21, 2021
Al Hanser, Founder, Chairman and President of The Sanibel Captiva Trust Company is pleased to announce the addition of Carolyn C. Rogers, CFRE, to the wealth services team as Senior Vice President.
My Account